CME Group ( NASDAQ:CME – Get Rating ) had its price objective lowered by JPMorgan Chase & Co. from $196.00 to $194.00 in a research report sent to investors on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the financial services provider's stock. CME has been the topic of several other research reports. Morgan Stanley raised their price target on CME Group from $201.00 to $208.00 and gave the company an equal weight rating in a research note on Tuesday, April 11th.

https://www.dailypolitical.com/2023/04/22/jpmorgan-chase-co-lowers-cme-group-nasdaqcme-price-target-to-194-00.html

#dailypolitical